PINL:GRPOF - Post by User
Comment by
FormerSupporteron Dec 16, 2020 12:09pm
159 Views
Post# 32119126
RE:RE:RE:RE:RE:RE:RE:RE:RE:Honestly i feel like i know so much about the company
RE:RE:RE:RE:RE:RE:RE:RE:RE:Honestly i feel like i know so much about the companyHey Friend! I still have over a million of shares in Tetra and a drop of that stock would seriously impact the share price so no just getting out would not be in anyone’s best interest. Furthermore, my comments are not bashing but observations. I have not made money on Tetra compared to other biotech stocks just like everyone else.
I fully agree with you that he needs to keep his investors in the loop. Today’s news release was nice but it didn’t mention anything on the size of revenue, timeline in 2021, costs or milestones that need to be completed. With these additional products does Tetra have to raise money. I'm not as sure on the lessons that have been learnt or not and only time will tell what that will look like. The fact that there hasn't been enough transparency from my perspective does not necessary show me that any lessons have been learnt.
What is the new priorities and game plan for advancing Tetra’s pipeline. It is clear that they didn’t have enough money to complete the QIXLEEF and ARDS trial simultaneously. How will they fund these initiatives as well.
Tetra has a huge potential but the realization of that potential is what is worrying me as a shareholder. Do I think it is too late and the company should be abandoned? Absolutely not or I would have sold and moved on. That said a tax loss might help if Tetra doesn’t announce a real value driving milestone has been reached and we can see a little more green. Guy is an amazing doctor and I believe a regulatory wizard but a public markets CEO, I’m not so sure.
I agree that earlier 2021 will be a make or break for Tetra. How will they position themselves to make the most of it, if they make it.